MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes

MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes

MISSISSAUGA, Ontario -- MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing a non-brokered Private Placement to accredited investors of up to $5 million by issuance of up to 100 Convertible Loan Notes, each with a face value of $50,000 (“Series IV Notes”). The Series IV Notes will bear interest at 6% per year, payable Quarterly, and will mature on December 31, 2028 (the “Maturity Date”). The Serie…